Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Tillmanns, H' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 79 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fassbender, WJ; Schluter, S; Stracke, H; Bretzel, RG; Waas, W; Tillmanns, H
      Thyroid function after contrast agent administration for coronary angiography - a prospective study in euthyroid patients

      ZEITSCHRIFT FUR KARDIOLOGIE
    2. Schwab, JO; Weber, S; Schmitt, H; Steen-Mueller, MK; Coch, M; Tillmanns, H; Becker, M; Lenzen, C; Waldecker, B
      Incidence of T wave alternation after acute myocardial infarction and correlation with other prognostic parameters: Results of a prospective study

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    3. Holschermann, H; Rascher, C; Oelschlager, C; Stapfer, G; Langenstein, A; Staubitz, A; Maus, U; Tillmanns, H; Bang, H; Haberbosch, W
      Opposite regulation of tissue factor expression by calcineurin in monocytes and endothelial cells

      JOURNAL OF IMMUNOLOGY
    4. Tillmanns, H
      Noninvasive acute therapy of myocardial infarction

      ANAESTHESIST
    5. Raedle-Hurst, TM; Wiecha, J; Schwab, JO; Schmitt, H; Hinrichs, M; Tillmanns, H; Waldecker, B
      Clinical performance of a specific algorithm to reconfirm self-terminatingventricular arrhythmias in current implantable cardioverter-defibrillators

      AMERICAN JOURNAL OF CARDIOLOGY
    6. Waldecker, B; Grempels, E; Waas, W; Haberbosch, W; Voss, R; Tillmanns, H
      Direct angioplasty eliminates sex differences in mortality early after acute myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    7. Schmitt, H; Weber, S; Schwab, JO; Voss, RM; Kneller, R; Tillmanns, H; Waldecker, B
      Diagnosis and ablation of focal right atrial tachycardia using a new nigh-resolution, non-contact mapping system

      AMERICAN JOURNAL OF CARDIOLOGY
    8. Haberbosch, W; Waas, W; Waldecker, B; Heizmann, H; Holschermann, H; Rau, M; Tillmanns, H
      Directional coronary atherectomy of in-stent restenosis: A two-center experience

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    9. Gardemann, A; Knapp, A; Katz, N; Tillmanns, H; Haberbosch, W
      No evidence for the CD31 C/G gene polymorphism as an independent risk factor of coronary heart disease

      THROMBOSIS AND HAEMOSTASIS
    10. Schmitt, H; Weber, S; Tillmanns, H; Waldecker, B
      Diagnosis and ablation of atrial flutter using a high resolution, noncontact mapping system

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    11. Holschermann, H; Hilgendorff, A; Kemkes-Matthes, B; Schonburg, M; Bauer, EP; Tillmanns, H; Haberbosch, W
      Simvastatin attenuates vascular hypercoagulability in cardiac transplant recipients

      TRANSPLANTATION
    12. Gardemann, A; Philipp, M; Hess, K; Katz, N; Tillmanns, H; Haberbosch, W
      The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease

      ATHEROSCLEROSIS
    13. Holschermann, H; Bohle, RM; Schmidt, H; Zeller, H; Fink, L; Stahl, U; Grimm, H; Tillmanns, H; Haberbosch, W
      Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts

      CIRCULATION
    14. Unkelbach, K; Gardemann, A; Kostrzewa, M; Philipp, M; Tillmanns, H; Haberbosch, W
      A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    15. Walker, G; Langheinrich, AC; Dennhauser, E; Bohle, RM; Dreyer, T; Kreuzer, J; Tillmanns, H; Braun-Dullaeus, RC; Haberbosch, W
      3-deazaadenosine prevents adhesion molecule expression and atheroscleroticlesion formation in the aortas of C57BL/6J mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    16. Jantos, CA; Nesseler, A; Waas, W; Baumgartner, W; Tillmanns, H; Haberbosch, W
      Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease

      CLINICAL INFECTIOUS DISEASES
    17. Braun-Dullaeus, RC; Feussner, M; Walker, G; Hopmann, H; Kraemer, HJ; Grimminger, F; Tillmanns, H; Haberbosch, W
      Cyclosporine-induced coronary artery constriction - Dissociation between thromboxane release and coronary vasospasm

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    18. Noll, T; Holschermann, H; Koprek, K; Gunduz, D; Haberbosch, W; Tillmanns, H; Piper, HM
      ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+](i)

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    19. Holschermann, H; Terhalle, HM; Zakel, U; Maus, U; Parviz, B; Tillmanns, H; Haberbosch, W
      Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives

      THROMBOSIS AND HAEMOSTASIS
    20. Gardemann, A; Lohre, J; Katz, N; Tillmanns, H; Hehrlein, FW; Haberbosch, W
      The 4G4G genotype of the plasminogen activator inhibitor 4G/5G gene polymorphism is associated with coronary atherosclerosis in patients at high riskfor this disease

      THROMBOSIS AND HAEMOSTASIS
    21. Gardemann, A; Arsic, T; Katz, N; Tillmanns, H; Hehrlein, FW; Haberbosch, W
      The factor II G20210A and factor V G1691A gene transitions and coronary heart disease

      THROMBOSIS AND HAEMOSTASIS
    22. Waldecker, B; Waas, W; Haberbosch, W; Voss, R; Goedecke, M; Tillmanns, H
      Acute myocardial infarction late after coronary artery bypass grafting: angiographic findings and results of an invasive approach

      ZEITSCHRIFT FUR KARDIOLOGIE
    23. Gardemann, A; Weidemann, H; Philipp, M; Katz, N; Tillmanns, H; Hehrlein, FW; Haberbosch, W
      The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease

      EUROPEAN HEART JOURNAL
    24. Waldecker, B; Waas, W; Haberbosch, W; Voss, R; Steen-Muller, MK; Hiddessen, A; Bretzel, R; Tillmanns, H
      Type 2 diabetes and acute myocardial infarction - Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients

      DIABETES CARE
    25. Gardemann, A; Stricker, J; Humme, J; Nguyen, QD; Katz, N; Philipp, M; Tillmanns, H; Hehrlein, FW; Haberbosch, W
      Angiotensinogen T174M and M235T gene polymorphisms are associated with theextent of coronary atherosclerosis

      ATHEROSCLEROSIS
    26. Gardemann, A; Mages, P; Katz, N; Tillmanns, H; Haberbosch, W
      The p22 phox A(640)G gene polymorphism but not the C242T gene variation isassociated with coronary heart disease in younger individuals

      ATHEROSCLEROSIS
    27. Holschermann, H; Bohle, RM; Zeller, H; Schmidt, H; Stahl, U; Fink, L; Grimm, H; Tillmanns, H; Haberbosch, W
      In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy

      AMERICAN JOURNAL OF PATHOLOGY
    28. WIECHA J; MUNZ B; WU Y; NOLL T; TILLMANNS H; WALDECKER B
      BLOCKADE OF CA2-ACTIVATED K+ CHANNELS INHIBITS PROLIFERATION OF HUMANENDOTHELIAL-CELLS INDUCED BY BASIC FIBROBLAST-GROWTH-FACTOR()

      Journal of vascular research
    29. WALDECKER B; WAAS W; HABERBOSCH W; VOSS R; HEIZMANN H; TILLMANNS H
      LONG-TERM FOLLOW-UP AFTER DIRECT PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION

      Journal of the American College of Cardiology
    30. GARDEMANN A; HUMME J; STRICKER J; NGUYEN QD; KATZ N; PHILIPP M; TILLMANNS H; HEHRLEIN FW; RAU M; HABERBOSCH W
      ASSOCIATION OF THE PLATELET GLYCOPROTEIN IIIA PL(A1 A2) GENE POLYMORPHISM TO CORONARY-ARTERY DISEASE BUT NOT TO NONFATAL MYOCARDIAL-INFARCTION IN LOW-RISK PATIENTS/

      Thrombosis and haemostasis
    31. GARDEMANN A; NGUYEN QD; HUMME J; STRICKER J; KATZ N; TILLMANNS H; HEHRLEIN FW; RAU M; HABERBOSCH W
      ANGIOTENSIN-II TYPE-1 RECEPTOR A1166C GENE POLYMORPHISM - ABSENCE OF AN ASSOCIATION WITH THE RISK OF CORONARY-ARTERY DISEASE AND MYOCARDIAL-INFARCTION AND OF A SYNERGISTIC EFFECT WITH ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM ON THE RISK OF THESE DISEASES

      European heart journal
    32. BRAUNDULLAEUS RC; FEUSSNER M; WALKER G; TILLMANNS H; HABERBOSCH W
      COMPARISON OF IN-VITRO CARDIOVASCULAR FUNCTION WITH IN-VIVO ECHOCARDIOGRAPHIC ASSESSMENT AFTER LONG-TERM ADMINISTRATION OF CYCLOSPORINE TO RATS

      Journal of cardiovascular pharmacology
    33. GARDEMANN A; FINK M; STRICKER J; NGUYEN QD; HUMME J; KATZ N; TILLMANNS H; HEHRLEIN FW; RAU M; HABERBOSCH W
      ACE I D GENE POLYMORPHISM - PRESENCE OF THE ACE-D ALLELE INCREASES THE RISK OF CORONARY-ARTERY DISEASE IN YOUNGER INDIVIDUALS/

      Atherosclerosis (Amsterdam)
    34. Gardemann, A; Ohly, D; Fink, M; Katz, N; Tillmanns, H; Hehrlein, FW; Haberbosch, W
      Association of the insertion/deletion gene polymorphism of the apolipoprotein B signal peptide with myocardial infarction

      ATHEROSCLEROSIS
    35. HOELSCHERMANN H; HILGENDORFF A; KEMKESMATTHES B; TILLMANNS H; HABERBOSCH W
      SIMVASTATIN REDUCES MONOCYTE TISSUE FACTOR ACTIVATION IN CARDIAC TRANSPLANT RECIPIENTS

      Circulation
    36. HOELSCHERMANN H; TERHALLE HM; ZAKEL U; TILLMANNS H; HABERBOSCH W
      MONOCYTE TISSUE FACTOR EXPRESSION IS ENHANCED IN WOMEN USING ORAL-CONTRACEPTIVES

      Circulation
    37. WU YJ; WALDECKER B; NOLL T; TILLMANNS H; WIECHA J
      BASIC FIBROBLAST-GROWTH-FACTOR (BFGF) MODULATES ENDOTHELIAL CALCIUM-ACTIVATED POTASSIUM CHANNELS BY G-PROTEIN-DEPENDENT AND TYROSINE KINASE-DEPENDENT MECHANISMS

      Circulation
    38. TOPOL E; CALIFF R; VANDEWERF F; DIAZ R; PAOLASSO E; AYLWARD P; SIMES J; COL J; PIEGAS L; ARMSTRONG P; LANGER A; GRANDE P; DEBONO D; HEIKKILA J; VAHANIAN A; NEUHAUS K; RUTSCH W; TOUTOUZAS P; KRISTINSSON A; TZIVONI D; ARDISSINO D; WHITE H; SEABRAGOMES R; BETRIU A; DALBY A; EMANUELSSON H; PFISTERER M; VERHEUGT F; SADOWSKI Z; BATES E; GIBLER W; GORE J; GRANGER C; GUERCI A; HARRINGTON R; HOCHMAN J; HOLMES D; KLEIMAN N; MOLITERNO D; MORRIS D; OHMAN E; WEAVER W; NEWBY K; KARNASH S; PEEKHACKENSON M; MABIE J; MELTON J; SNAPP J; BROWN D; DABOLT N; GREENE C; MCCLANAHAN M; STRAND G; TARDIFF B; WINCHELL M; BOLTE J; EVANS R; POKU M; CONDER S; TINNIN K; LLOYD W; JACKSON G; LEE K; BHAPKAR M; SENSE W; PASSMORE D; KONCZOS L; CAOUETTE S; MARTIN S; SUTHERLAND W; LUYTEN A; TOBBACK L; HOUBRACKEN K; BROWER R; DHOORE L; KEECH A; KAVA M; FRYE R; CHEITLIN M; DEMETS D; FISHER L; JEFFERY I; TAVERNER P; WALSH W; FRIEND C; LEITCH J; COX K; FREEDMAN B; GAYNOR M; CAMPBELL T; DARCY S; OWENSBY D; DAVIDSON T; RAMSEY D; QUINN W; VERZOSA M; WIKRAMANAYAKE R; MANNERS G; WAITES J; CAHILL P; WOODS J; KEARNEY A; FITZPATRICK D; SCHOEVERS D; HUNT D; SALLABERGER M; FEDERMAN J; BRIGGS H; APPELBE A; MILLER M; NEWMAN R; PEELER C; LEFKOVITS J; ROBERTS L; COUNSELL J; MARTIN M; SOWARD A; BREEDING J; TONKIN A; BROWN L; CROSS D; FITZPATRICK L; GARRAHY P; HALL C; GNANAHARAN C; ARMSTRONG C; CARROLL P; DUROUX M; LIM C; COOKE B; COVERDALE S; JOY L; OBRIEN D; ARONEY G; HICKS P; ARNOLDER L; HOROWITZ J; LESLEY S; STEWART S; THOMPSON P; BRADSHAW P; HENICKS R; GARRETT J; SINGH B; DECAMPO M; SWIATECKA G; PIWOWARSKA W; TADEUSZ P; NARTOWICS E; KRASKA T; GIEC L; DYDUSZYNSKI A; STEPINSKA J; GORSKI J; ZDZISLAWA KJ; CZESTOCHOWSKA E; KAZIMIERZ J; WIERZCHOWIECKI M; CIESLINSKI A; CEREMUZYNSKI L; LOBOZGRUDZIEN K; KRZEMINSKAPAKULA M; KRZYSZTOF W; WODNIECKI Z; ALIOT; BONOT; CASSAT; CAZAUX; CHESTIER; COHEN; SOLAL C; FAGART; FRUCHAUD; FUNCK F; GODIN; RAOUX; KHALIFE; MOSSARD; NALLET; NORMAND; PECHEUX; PEZZANO; QUIRET; SANS; SLAMA M; TOUSSAINT; THANH T; VEDEL; VITOUX B; HALINEN M; NAUKKARINEN V; NURMINEN J; KOSKELA E; MELIN J; KOSHIVIRTA H; KIVELA H; RYNEN M; NIEMI AK; GILLEBERT; CROONENBERGHS; DIRK B; VANWALLEGHEM; KOENTGES; VERMEERSCH; VERSTREKEN; VANDORPE; VANSCHUYLENBERGH; CAENEPEEL; CLAESSENS; VANMIEGHEM; STROOBANDT; EERDEKENS; LIGNIAN; DEJAEGHER; DEMEESTER; DESCHEPER; ELSSCHOT; SCHURMANS; THOENG; EMMERECHTS; THIELS; POPEYE; GOETHALS; OTTANI F; VECCHIO C; ORLANDI M; CAPUCCI A; POLITI A; MAURI F; ROVELLI G; MONTEMARTINI C; VAJOLA S; PEZZANO A; BRUSCA A; DEVITA C; PINELLI G; BRANZI A; PAOLO S; IGNONE G; BERNI G; TARTAGNI F; CERNIGLIARO C; RUSTICALI F; CORSINI G; POLESE A; MORGAN C; FRESKIW K; MACRITCHIE S; SWEENEY R; TYMCHAK W; KEE C; FINNIE K; MCCREERY M; HEATH J; THOMPSON M; SUAVE M; SZLACHETKA B; GEBHARDT V; TAYLOR J; CAMERON W; NOSEWORTHY C; ERVIN F; LECLAIR S; HUI W; KVILL L; MCDOWELL J; ZIEMSKI R; GOSSARD D; MAGNON O; TREMBLEY G; SENARATNE M; GOERES M; CURLEY S; GREENWOOD P; PROSSER A; LOPEZ J; KUNY P; HARRISON W; MASKE L; RIBEIRO P; BISHOP V; RASKIN S; CARR J; BUSHBINDER M; KOESTER S; GERSHONY G; ATHERTONPIERCE B; PELLER O; SCHOFEL P; SMITH J; SULLIVAN C; CHANDLER AB; EDWARDS M; GAINEY P; ARSENAUL S; WHITE R; VANHAM S; CHENG T; MONROE C; HAHN R; QUINN D; DENNY D; MCCARTNEY T; WEISS R; THORNTONCHANDLER D; MARTZ C; NILES N; KENNEDY S; GOSS J; GOEBEL S; MILLAR R; ZOLEZZI K; MASUD Z; GIAMBRA T; CHRISTIEGULOTTA C; BHALODKAR N; VALERIA A; JURAN N; SHAH A; EDEL C; LEIMBACH W; DURHAM J; KOZAK M; ZIMMERMAN H; DIBATTISTE P; POSKUS D; PERRY J; SCHVANEVELDT W; NYGAARD T; WHITE J; MACDONALD G; SEGEL S; LEHMANN K; PLATT M; SINGH S; SESING J; NOBLE W; NOBLE DB; HART H; BRANNIGAN H; DURHAM D; CURRIE R; LUKE R; SCHMID D; LEWIS G; BENT M; BRUNS B; LILEY M; MORLEY A; PATEL H; WATTS V; LESLIE P; SAUNDERS K; IILRAM H; LAWSON T; MANN S; DEWAR J; FRIEDLANDER D; LOW L; HAMER A; TOMLINSON J; JARDINE D; CARSTENSEN P; WILKINS G; BLOK M; AUDEAU M; SMART A; CHIA G; MEGEE S; BUSH L; HERTZBERGER D; CIAMPRICOTTI R; VANROSSUM P; ROETERSVANLENNEP G; BONNIER H; LUTTERMAN B; GOMEN A; ENGBERS J; BERNINK P; CHIN J; VANLOENHOUT T; WELY L; NODABY; MARCOS; CASTELLANOS; PERRINO O; HASBANI EG; BONO JO; GAMBARTE AJ; RAMOS JL; ZAPATA G; GARCIA J; PELLEGRINI C; SIMON S; COVELLI G; BARBAGELATA A; MELE; SAMPO EA; ODDSON G; SVERRISSON JT; TZIVONI; ABINADER; ROGUIN; REISIN; CASPI; MARMOR; CHEN S; ZAHAVI; SCLAROVSKI; KASSIS E; THYGESEN K; HANSEN JF; MADSEN H; AGNER E; RASMUSSEN SL; PINDBORG T; HILDEBRANDT P; NIELSEN HV; KIKIS D; HOSSMANN V; DITTER H; CYRON I; BECK OA; ASSMANN I; ALTMANN KE; NAST HP; MULLERESCH G; SCHUSEN KP; KETTNER W; BACHMANN; TILLMANNS H; ALTHOFF FR; LUDERITZ B; MAISCH B; VOHRINGER HF; VONWISSMANN C; DISSMANN; BARCHOW D; SCHWERFFENER F; WAGNER J; ZWIRNER K; DANIEL GW; KOCHS M; GRIEBENOW R; BOLTE HD; MATISONN RE; MILHA AS; ESSOP AR; JARDINE RM; GEBKA MK; CASSEL GA; MYBURGH DP; SNYDERS F; BENNETT JM; SPILKIN S; MABIN T; DALMEIDA VC; GIL JC; PINHEIRO N; SANTOS L; PROVIDENCIA L; ALMEIDA J; RAMOS A; DOSSANTOS JC; INES L; DASILVA GF; FERREIRA R; LEIRIA JG; CARRAGETA M; GONSALVES A; RIBEIRO C; RISENFORS M; SANDSTEDT L; ADJORN C; CHRISTENSEN K; STEPHENS J; NORTHCOTE R; MILLARCRAIG M; MCCANCE A; MACIVER D; ROSEN E; FERNANDO RR; NICOLAU J; CARVALHO D
      INTERNATIONAL, RANDOMIZED, CONTROLLED TRIAL OF LAMIFIBAN (A PLATELET GLYCOPROTEIN IIB IIIA INHIBITOR), HEPARIN, OR BOTH IN UNSTABLE ANGINA/

      Circulation
    39. TIEFENBACHER CP; TILLMANNS H; NIROOMAND F; ZIMMERMANN R; KUBLER W
      ADAPTATION OF MYOCARDIAL BLOOD-FLOW TO INCREASED METABOLIC DEMAND IS NOT DEPENDENT ON ENDOTHELIAL VASODILATORS IN THE RAT-HEART

      HEART
    40. GARDEMANN A; SCHWARTZ O; HABERBOSCH W; KATZ N; WEISS T; TILLMANNS H; HEHRLEIN FW; WAAS W; EBERBACH A
      POSITIVE ASSOCIATION OF THE BETA-FIBRINOGEN H1 H2 GENE VARIATION TO BASAL FIBRINOGEN LEVELS AND TO THE INCREASE IN FIBRINOGEN CONCENTRATIONDURING ACUTE-PHASE REACTION BUT NOT TO CORONARY-ARTERY DISEASE AND MYOCARDIAL-INFARCTION/

      Thrombosis and haemostasis
    41. VOSTEEN S; MATZDORFF A; SCARLAT T; TILLMANNS H; VOSS R
      ASSESSMENT OF PLATELET ACTIVATION IN CARDIAC PATIENTS

      Thrombosis and haemostasis
    42. HOLSCHERMANN H; KOHL O; MAUS U; TILLMANNS H; HABERBOSCH W
      THE EFFECT OF CYCLOSPORINE ON MONOCYTE TISSUE FACTOR EXPRESSION IN CARDIAC TRANSPLANT RECIPIENTS

      Thrombosis and haemostasis
    43. WALDECKER B; WAAS W; HABERBOSCH W; VOSS R; TILLMANNS H
      IN-HOSPITAL RESULTS AND LONG-TERM FOLLOW- UP OF DIRECT PTCA IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Zeitschrift fur Kardiologie
    44. HABERBOSCH W; WAAS W; HEIZMANN H; WALDECKER B; VOSS R; TILLMANNS H
      DIRECTIONAL CORONARY ATHERECTOMY - COMPAR ISON OF EARLY AND RECENT RESULTS

      Zeitschrift fur Kardiologie
    45. VOSS R; TILLMANNS H
      NEW ASPECTS OF ANTITHROMBOTIC TREATMENT I N UNSTABLE ANGINA-PECTORIS

      Zeitschrift fur Kardiologie
    46. NEUHOF C; SOEFFKER G; CERNAIANU G; DAPPER F; TILLMANNS H; NEUHOF H
      EFFECT OF BRADYKININ B2-RECEPTOR ANTAGONISM ON POSTISCHEMIC CORONARY REPERFUSION

      Immunopharmacology
    47. HURST TM; KRIEGLSTEIN H; TILLMANNS H; WALDECKER B
      INAPPROPRIATE MANAGEMENT OF SELF-TERMINATING VENTRICULAR ARRHYTHMIAS BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS DESPITE A SPECIFIC RECONFIRMATION ALGORITHM - A REPORT OF 2 CASES

      PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    48. KOPREK K; HOLSCHERMANN H; NOLL T; HABERBOSCH W; TILLMANNS H; PIPER HM
      ATP REDUCES MACROMOLECULE PERMEABILITY OF ENDOTHELIAL MONOLAYERS DESPITE INCREASING CYTOSOLIC CALCIUM-CONCENTRATION

      Pflugers Archiv
    49. TIEFENBACHER CP; EBERT M; NIROOMAND F; BATKAI S; TILLMANNS H; ZIMMERMANN R; KUBLER W
      INHIBITION OF ELASTASE IMPROVES MYOCARDIAL-FUNCTION AFTER REPETITIVE ISCHEMIA AND MYOCARDIAL-INFARCTION IN THE RAT-HEART

      Pflugers Archiv
    50. HABERBOSCH W; BOHLE RM; FRANKE FE; DANILOV S; ALHENCGELAS F; BRAUNDULLAEUS R; HOLSCHERMANN H; WAAS W; TILLMANNS H; GARDEMANN A
      THE EXPRESSION OF ANGIOTENSIN-I CONVERTING-ENZYME IN HUMAN ATHEROSCLEROTIC PLAQUES IS NOT RELATED TO THE DELETION INSERTION POLYMORPHISM BUT TO THE RISK OF RESTENOSIS AFTER CORONARY INTERVENTIONS/

      Atherosclerosis
    51. NEUHOF C; LANG I; SOEFFKER G; HABERBOSCH W; TILLMANNS H; NEUHOF H
      ROLE OF POLYMORPHONUCLEAR NEUTROPHILS IN MYOCARDIAL-ISCHEMIA AND REPERFUSION IN ISOLATED-PERFUSED RABBIT HEARTS

      Circulation
    52. KOPREK K; HOLSCHERMANN H; NOLL T; HABERBOSCH W; TILLMANNS H; PIPER HM
      ATP REDUCES MACROMOLECULE PERMEABILITY OF ENDOTHELIAL MONOLAYERS DESPITE INCREASING CYTOSOLIC CA2+ CONCENTRATION

      Circulation
    53. HOLSCHERMANN H; KOHL O; MAUS U; DURFELD F; BIERHAUS A; NAWROTH PP; LOHMEYER J; TILLMANNS H; HABERBOSCH W
      CYCLOSPORINE-A INHIBITS MONOCYTE TISSUE FACTOR ACTIVATION IN CARDIAC TRANSPLANT RECIPIENTS

      Circulation
    54. VOSS R; SCARLAT T; MATZDORFF A; TILLMANNS H
      FLOW CYTOMETRIC DETECTION OF PLATELET ACTIVATION IN PATIENTS UNDERGOING DIAGNOSTIC AND INTERVENTIONAL CORONARY ANGIOGRAPHY

      Platelets
    55. HURST TM; KILLAT H; STERTMANN WA; KRIEGLSTEIN H; TILLMANNS H; WALDECKER B
      BINARY SEARCH ALGORITHM VERSUS STEP-DOWN PROTOCOL TO ASSESS THE INTRAOPERATIVE DEFIBRILLATION THRESHOLD (DFT) - CAN THE IMPLANTATION PROCEDURE BE SHORTENED

      Circulation
    56. HURST TM; KATZ N; BREIDENBACH C; NORDLOHNE M; TILLMANNS H; WALDECKER B
      MYOCARDIAL-CELL INJURY DURING TRANSVENOUS IMPLANTATION OF AUTOMATIC CARDIOVERTER-DEFIBRILLATORS

      Circulation
    57. ZIMMERMANN R; MURA R; WENDE P; ZEHELEIN J; HOFFEND J; TIEFENBACHER CP; DENGLER TJ; TILLMANNS H
      PERSISTENT TRACER DEFECTS AT DIPYRIDAMOLE-THALLIUM IMAGING AS INDEPENDENT PREDICTORS OF RESTENOSIS AFTER CORONARY STENTING

      Circulation
    58. WALDECKER B; WAAS W; HABERBOSCH W; VOSS R; HEIZMANN H; KISTLER P; TILLMANNS H
      CORONARY EVENTS AND REINTERVENTIONS EARLY AND LATE AFTER DIRECT ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION - 2.5 YEARS OF FOLLOW-UP IN 352PATIENTS

      Circulation
    59. HOLSCHERMANN H; DURFELD F; MAUS U; BIERHAUS A; HEIDINGER K; LOHMEYER J; NAWROTH PP; TILLMANNS H; HABERBOSCH W
      CYCLOSPORINE-A INHIBITS TISSUE FACTOR EXPRESSION IN MONOCYTES MACROPHAGES/

      Blood
    60. HOLSCHERMANN H; DURFELD F; MAUS U; TILLMANNS H; HABERBOSCH W
      CYCLOSPORINE DECREASES THE PROCOAGULATORY ACTIVITY OF STIMULATED HUMAN MONOCYTES

      Thrombosis and haemostasis
    61. WALDECKER B; WAAS W; HEIZMANN H; HABERBOSCH W; VOSS R; WALKER G; SCHAFER M; KISTLER P; TILLMANNS H
      PTCA FOR ACUTE MYOCARDIAL-INFARCTION IN PATIENTS NOT ELIGIBLE FOR IV THROMBOLYSIS - IN-HOSPITAL RESULTS

      Fibrinolysis
    62. TIEFENBACHER CP; ZIMMERMANN R; PAREKH N; AMANN K; TILLMANNS H; RAUCH B; KUBLER W
      PRESERVATION OF MYOCARDIAL BLOOD-FLOW BY CALCIUM-ANTAGONISTS DOES NOTPREVENT ATTENUATION OF REGIONAL MYOCARDIAL-FUNCTION AFTER REPETITIVE BRIEF PERIODS OF MYOCARDIAL-ISCHEMIA IN THE RAT-HEART

      European heart journal
    63. WALDECKER B; WAAS W; HABERBOSCH W; VOSS R; KISTLER P; TILLMANNS H
      LONG-TERM FOLLOW-UP (2.5 YEARS) OF 300 CONSECUTIVE PATIENTS WITH PRIMARY ANGIOPLASTY FOR ACUTE MYOCARDIAL-INFARCTION

      Circulation
    64. HURST T; KILLAT H; STERTMANN W; KRIEGLSTEIN H; TILLMANNS H; WALDECKER B
      ARE THERE DIFFERENCES IN ARRHYTHMIAS INDUCED BY BURST PACING VERSUS T-WAVE SHOCK

      Circulation
    65. HOLSCHERMANN H; DURFELD F; MAUS U; HEIDINGER K; BIERHAUS A; NAWROTH PP; TILLMANNS H; HABERBOSCH W
      CYCLOSPORINE-A REGULATES TISSUE FACTOR EXPRESSION ON HUMAN MONOCYTES

      Circulation
    66. GARDEMANN A; WEISS T; SCHWARTZ O; EBERBACH A; KATZ N; HEHRLEIN FW; TILLMANNS H; WAAS W; HABERBOSCH W
      GENE POLYMORPHISM BUT NOT CATALYTIC ACTIVITY OF ANGIOTENSIN I-CONVERTING ENZYME IS ASSOCIATED WITH CORONARY-ARTERY DISEASE AND MYOCARDIAL-INFARCTION IN LOW-RISK PATIENTS

      Circulation
    67. ZIMMERMANN R; MALL G; RAUCH B; ZIMMER G; GABEL M; ZEHELEIN J; BUBECK B; TILLMANNS H; HAGL S; KUBLER W
      RESIDUAL TL-201 ACTIVITY IN IRREVERSIBLE DEFECTS AS A MARKER OF MYOCARDIAL VIABILITY CLINICOPATHOLOGICAL STUDY

      Circulation
    68. AHERN TS; ALPERT BL; BARDY GH; BECKMAN K; BENDITT DG; BERENBOM LD; BHANDARI AK; BRODINE WN; CASSIDY DM; CHAPMAN PD; CHILSON DA; DENKER ST; ECHT DS; EDEL TB; FISHER JD; FLETCHER RD; FOGOROS RN; FURMAN S; GALLASTEGUI JL; GOHN DC; GOTTLIEB CD; GREER GS; GRIFFIN JC; HAFFAJEE CI; HAMMILL SC; HAYES JJ; HUANG SKS; SMITH I; IRWIN JM; JACKMAN WM; JANOSIK DL; JOSEPHSON M; KENNEDY EE; KOPELMAN HA; KREMERS MS; KRON J; LEHMAN MH; LEON AR; LINDSAY BD; LUCERI RM; LUDMER PL; MAHMUD R; MATTIONI TA; MCCLELLAND JH; MCCOWAN RJ; MILES WM; MORADY F; NACCARELLI GV; OSBORN JS; OTOOLE MF; PETER CT; PLATIA EV; PORTERFIELD JG; PRITZKER M; SELLERS TD; SHARMA AD; SHIROFF RA; SPIELMAN SR; STAMATO A; STEINMAN RT; SUNG RJ; SWERDLOW CD; SWITZER DF; TRANTHAM JL; WALTER PF; WHELAN KR; WILBER DJ; WINKLE RA; ZAHER M; ZIPES DP; CONNOLLY SJ; DORIAN P; DOWNAR E; DUBUC M; GULAMHUSEIN S; MITCHELL LB; SAMI MH; TANG ASL; YEE R; ALIOT E; ALMENDRAL J; AMLIE J; ANDRESEN D; BENEDINI G; BERTULLA A; BLOMSTROMLUNDQVIST C; BRACHMANN J; BREITHARDT G; CAMM AJ; CLARKE M; COUMEL P; DAVIES DW; FAVALE S; FURLANELLO F; HEUER H; HOPP W; JORDAENS LJ; KACET S; KAPPENBERGER LJ; KLEIN W; KUCK KH; KULBERTUS HE; LEVY S; LUDERITZ B; LYTTWIN R; MCCOMB JM; SERRANO CM; NATHAN AW; OBEL IWP; OHM OJ; PAPPONE C; PERRINS EJ; ROSENQVIST M; ROWLAND E; SABIN G; SCHMIDINGER H; SOWTON E; STEINBACH K; STEINBECK G; SUTTON R; TILLMANNS H; TOUBOUL PP; WEHR M; WELLENS HJJ; WITTE J
      CLINICAL OUTCOME OF PATIENTS WITH MALIGNANT VENTRICULAR TACHYARRHYTHMIAS AND A MULTIPROGRAMMABLE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTED WITH OR WITHOUT THORACOTOMY - AN INTERNATIONAL MULTICENTER STUDY

      Journal of the American College of Cardiology
    69. WALDECKER B; BRACHMANN J; SCHMITT C; KILLAT H; SAGGAU W; STERTMANN WA; DAPPER F; HEHRLEIN FW; TILLMANNS H; KUBLER W
      CARDIAC-RHYTHM FOLLOWING CONVERSION OF VENTRICULAR TACHYARRHYTHMIAS BY INTERNAL SHOCK DELIVERY

      Zeitschrift fur Kardiologie
    70. NEUMANN FJ; OTT I; WILHELM A; KATUS H; TILLMANNS H; SCHOMIG A
      RELEASE OF CHEMOATTRACTANTS AND NEUTROPHIL ACTIVATION IN ACUTE MYOCARDIAL-INFARCTION IMMEDIATELY AFTER SUCCESSFUL RECANALIZATION OF THE INFARCT-RELATED VESSEL BY ANGIOPLASTY

      European heart journal
    71. HABERBOSCH W; BOHLE RM; OKSCHE A; WAAS W; HEINRICHS CM; MORR H; REIS T; TILLMANNS H
      ADENOCARCINOMA OF THE LUNG WITH UNUSUAL I NVASION OF METASTASES INTO THE PERICARDIUM

      Die medizinische Welt
    72. HOBERG E; DIETZ R; FREES U; KATUS HA; RAUCH B; SCHOMIG A; SCHULER G; SCHWARZ F; TILLMANNS H; NIEBAUER J; KUBLER W
      VERAPAMIL TREATMENT AFTER CORONARY ANGIOPLASTY IN PATIENTS AT HIGH-RISK OF RECURRENT STENOSIS

      British Heart Journal
    73. TILLMANNS H; NEUMANN FJ; TIEFENBACHER C; DORIGO O; PAREKH N; WAAS W; ZIMMERMANN R; STEINHAUSEN M; KUEBLER W
      ACTIVATION OF NEUTROPHILS IN THE MICROVASCULATURE OF THE ISCHEMIC ANDREPERFUSED MYOCARDIUM

      European heart journal
    74. VOSS R; GEISSLER BS; TILLMANNS H; MATTHIAS FR
      IN-VITRO AND EX-VIVO EFFECTS OF ASPIRIN IN PATIENTS ON A LOW-DOSE ASPIRIN THERAPY

      Thrombosis research
    75. OLSCHEWSKI H; WALMRATH HD; TILLMANNS H; TEMMESFELDWOLLBRUCK B; SCHUTTERLE G; SEEGER W
      PULMONARY-HYPERTENSION - DIAGNOSIS, THERA PY AND PROGNOSIS

      Die medizinische Welt
    76. HABERBOSCH W; BOHLE RM; DAPPER F; HEHRLEIN F; HEIDT M; WAAS W; WALDECKER B; WEBER J; TILLMANNS H
      TRANSESOPHAGEAL ECHOCARDIOGRAPHY - CLINIC AL RELEVANCE

      Die medizinische Welt
    77. ZIMMERMANN R; TILLMANNS H; RAUCH B; MALL G; HAGL S
      STRUCTURAL ALTERATIONS AND THE EFFECT OF CORONARY REVASCULARIZATION IN MYOCARDIAL REGIONS WITH MILD-TO-MODERATE OR SEVERE PERSISTENT TL-201DEFECTS

      Circulation
    78. NEUMANN FJ; RICHARDT G; SCHNEIDER M; OTT I; HAUPT HM; TILLMANNS H; SCHOMIG A; RAUCH B
      CARDIAC RELEASE OF CHEMOATTRACTANTS AFTER ISCHEMIA-INDUCED BY CORONARY BALLOON ANGIOPLASTY

      British Heart Journal
    79. HORNIG CR; MAST H; BRAININ M; DORNDORF W; MARX P; TILLMANNS H; STOLLBERGER C
      CARDIOGENIC EMBOLIC STROKE

      Deutsche Medizinische Wochenschrift


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 12:55:42